Zach Gobst is the founder and CEO of Leapcure, a medtech company that accelerates clinical research by connecting patients with trials. Previously, Zach held roles in operations and strategy at Sanguine, Verity, and Cummins. His experience in clinical research revealed the transformative impact of patient and advocacy engagement, which inspired him to create Leapcure. By integrating patient feedback and advocacy group insights, Leapcure enhances research relevance and accelerates outcomes.